Role of MCP-1 as an inflammatory biomarker in nephropathy
Open accessThe DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.
Abstract
The Monocyte chemoattractant protein-1 (MCP-1), also referred to as chemokine ligand 2 (CCL2), belongs to the extensive chemokine family and serves as a crucial mediator of innate immunity and tissue inflammation. It has a notable impact on inflammatory conditions affecting the kidneys. Upon binding to its receptor, MCP-1 can induce lymphocytes and NK cells’ homing, migration, activation, differentiation, and development while promoting monocytes’ and macrophages’ infiltration, thereby facilitating kidney disease-related inflammation. As a biomarker for kidney disease, MCP-1 has made notable advancements in primary kidney diseases such as crescentic glomerulonephritis, chronic glomerulonephritis, primary glomerulopathy, idiopathic proteinuria glomerulopathy, acute kidney injury; secondary kidney diseases like diabetic nephropathy and lupus nephritis; hereditary kidney diseases including autosomal dominant polycystic kidney disease and sickle cell kidney disease. MCP-1 not only predicts the occurrence, progression, prognosis of the disease but is also closely associated with the severity and stage of nephropathy. When renal tissue is stimulated or experiences significant damage, the expression of MCP-1 increases, demonstrating a direct correlation with the severity of renal injury.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A guide to chemokines and their receptors
Hughes, C. E., & Nibbs, R. J. B. (2018) · The FEBS Journal · doi:10.1111/febs.14466 · Cited by 1,412
MCP-1: Function, regulation, and involvement in disease
Singh, S., Anshita, D., & Ravichandiran, V. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107598 · Cited by 883
Lv, W., Booz, G. W., Wang, Y., Fan, F., & Roman, R. J. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.12.016 · Cited by 338
Pathophysiologic Mechanisms and Potential Biomarkers in Diabetic Kidney Disease
Jung, C.-Y., & Yoo, T.-H. (2022) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2021.0329 · Cited by 262
Chemokines from a Structural Perspective
Miller, M., & Mayo, K. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18102088 · Cited by 235
Monocyte chemoattractant protein-1 and the kidney
Haller, H., Bertram, A., Nadrowitz, F., & Menne, J. (2016) · Current Opinion in Nephrology and Hypertension · doi:10.1097/mnh.0000000000000186 · Cited by 184
The Promise of Tubule Biomarkers in Kidney Disease: A Review
Ix, J. H., & Shlipak, M. G. (2021) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2021.03.026 · Cited by 180
Schrauben, S. J., Shou, H., Zhang, X., Anderson, A. H., Bonventre, J. V., Chen, J., Coca, S. G., Furth, S. L., Greenberg, J. H., Gutiérrez, O. M., et al. (2020) · Journal of the American Society of Nephrology · doi:10.1681/asn.2020040487 · Cited by 164
Role of the CCL2-CCR2 axis in cardiovascular disease: Pathogenesis and clinical implications
Zhang, H., Yang, K., Chen, F., Liu, Q., Ni, J., Cao, W., Hua, Y., He, F., Liu, Z., Li, L., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.975367 · Cited by 134
Role of Macrophages and Related Cytokines in Kidney Disease
Cantero‐Navarro, E., Rayego‐Mateos, S., Orejudo, M., Tejedor-Santamaria, L., Tejera‐Muñoz, A., Sanz, A. B., Márquez‐Expósito, L., Marchant, V. A., Santos‐Sanchez, L., Egido, J., et al. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.688060 · Cited by 129
Nadkarni, G. N., Rao, V., Ismail-Beigi, F., Fonseca, V. A., Shah, S. V., Simonson, M. S., Cantley, L., Devarajan, P., Parikh, C. R., & Coca, S. G. (2016) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.12051115 · Cited by 114
Mcp1 Promotes Macrophage-Dependent Cyst Expansion in Autosomal Dominant Polycystic Kidney Disease
Cassini, M. F., Kakade, V. R., Kurtz, E., Sulkowski, P., Glazer, P., Torres, R., Somlo, S., & Cantley, L. G. (2018) · Journal of the American Society of Nephrology · doi:10.1681/asn.2018050518 · Cited by 112
Titan, S., Vieira, J. M., Dominguez, W. V., Moreira, S. R. S., Pereira, A. B., Barros, R. T., & Zatz, R. (2012) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2012.06.006 · Cited by 111
Galipeau, J. (2021) · Stem Cells · doi:10.1002/stem.3380 · Cited by 88
Longitudinal biomarkers and kidney disease progression after acute kidney injury
Wen, Y., Xu, L., Melchinger, I., Thiessen‐Philbrook, H., Moledina, D. G., Coca, S. G., Hsu, C., Go, A. S., Liu, K. D., Siew, E. D., et al. (2023) · JCI Insight · doi:10.1172/jci.insight.167731 · Cited by 84
Twist1 regulates macrophage plasticity to promote renal fibrosis through galectin-3
Wu, Q., Sun, S., Lei, W., Liu, M., Liu, H., Liu, T., Zhou, Y., Jia, Q., Wang, D., Yang, Z. L., et al. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04137-0 · Cited by 80
Shoukry, A., Bdeer, S. E., & El-Sokkary, R. H. (2015) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-015-2479-y · Cited by 73
Role of the intrarenal renin–angiotensin system in the progression of renal disease
Urushihara, M., & Kagami, S. (2016) · Pediatric Nephrology · doi:10.1007/s00467-016-3449-7 · Cited by 70
Pena, M. J., Heinzel, A., Heinze, G., Alkhalaf, A., Bakker, S. J. L., Nguyen, T. Q., Goldschmeding, R., Bilo, H. J. G., Perco, P., Mayer, B., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0120995 · Cited by 66
New Understanding on the Role of Proteinuria in Progression of Chronic Kidney Disease
Liu, D., & Lv, L. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-8871-2_24 · Cited by 63
Bullen, A. L., Katz, R., Jotwani, V., Garimella, P. S., Lee, A. K., Estrella, M. M., Shlipak, M. G., & Ix, J. H. (2021) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2021.01.021 · Cited by 59
Composite urinary biomarkers to predict pathological tubulointerstitial lesions in lupus nephritis
Ding, Y., Nie, L.-M., Pang, Y., Wu, W.-J., Tan, Y. C. R. S., Yu, F., & Zhao, M. (2018) · Lupus · doi:10.1177/0961203318788167 · Cited by 56
Urinary MCP-1 as diagnostic and prognostic marker in patients with lupus nephritis flare
Singh, R. G., Panihar, U., Rathore, S., Behura, S. K., & Nk, S. (2012) · Lupus · doi:10.1177/0961203312452622 · Cited by 55
Greenberg, J. H., Abraham, A. G., Xu, Y., Schelling, J. R., Feldman, H. I., Sabbisetti, V. S., Ix, J. H., Jogalekar, M. P., Coca, S. G., Waikar, S. S., et al. (2021) · Journal of the American Society of Nephrology · doi:10.1681/asn.2021010094 · Cited by 54
MCP‑1 targeting: Shutting off an engine for tumor development (Review)
Wang, L., Lan, J., Tang, J., & Luo, N. (2021) · Oncology Letters · doi:10.3892/ol.2021.13144 · Cited by 54
Rapid Progression of Autosomal Dominant Polycystic Kidney Disease: Urinary Biomarkers as Predictors
Messchendorp, A. L., Meijer, E., Visser, F. W., Engels, G. E., Kappert, P., Losekoot, M., Peters, D. J. M., Gansevoort, R. T., & on behalf of the DIPAK-1 study investigators (2019) · American Journal of Nephrology · doi:10.1159/000502999 · Cited by 53
Role of MCP-1/CCR2 axis in renal fibrosis: Mechanisms and therapeutic targeting
He, S., Yao, L., & Li, J. (2023) · Medicine · doi:10.1097/md.0000000000035613 · Cited by 52
Gong, X., Yiru, D., Zheng, J., Ye, Z., & Hei, T. K. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/7096912 · Cited by 51
Messchendorp, A. L., Meijer, E., Boertien, W. E., Engels, G. E., Casteleijn, N. F., Spithoven, E. M., Losekoot, M., Burgerhof, J. G. M., Peters, D. J. M., & Gansevoort, R. T. (2017) · Kidney International Reports · doi:10.1016/j.ekir.2017.10.004 · Cited by 48
Plasma and Urine Biomarkers of CKD: A Review of Findings in the CKiD Study
Sandokji, I. A., & Greenberg, J. H. (2021) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2021.09.003 · Cited by 47
Worawichawong, S., Worawichawong, S., Radinahamed, P., Muntham, D., Sathirapongsasuti, N., Nongnuch, A., Assanatham, M., & Kitiyakara, C. (2016) · Kidney & Blood Pressure Research · doi:10.1159/000452595 · Cited by 46
Kashyap, S., Warner, G. M., Hartono, S. P., Boyilla, R., Knudsen, B. E., Zubair, A. S., Lien, K. R., Nath, K. A., Textor, S. C., Lerman, L. O., et al. (2015) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00131.2015 · Cited by 45
Epigenetic regulation of chemokine ( CC ‐motif) ligand 2 in inflammatory diseases
Chen, Y., Liu, S., Wu, L., Liu, Y., Du, J., Luo, Z., Xu, J., Guo, L., & Liu, Y. F. (2023) · Cell Proliferation · doi:10.1111/cpr.13428 · Cited by 43
Self-citationFufaa, G. D., Weil, E. J., Nelson, R. G., Hanson, R. L., Knowler, W. C., Rovin, B. H., Wu, H., Klein, J. B., Mifflin, T. E., Feldman, H. I., et al. (2015) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfv012 · Cited by 41
Devarapu, S. K., Kumar, S. V. R., Rupanagudi, K. V., Kulkarni, O. P., Eulberg, D., Klußmann, S., & Anders, H. (2016) · Clinical Immunology · doi:10.1016/j.clim.2016.07.003 · Cited by 41
Gupta, R., Yadav, A., & Aggarwal, A. (2016) · Clinical Rheumatology · doi:10.1007/s10067-016-3404-9 · Cited by 40
Dong, X., Zheng, Z., Luo, X., Ding, J., Li, Y., Li, Z., Li, S., Rong, M., Fu, Y., Wu, Z., et al. (2018) · Medicine · doi:10.1097/md.0000000000010343 · Cited by 33
Self-citationTam, F. W. K., & Ong, A. C. M. (2019) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfz082 · Cited by 32
Characteristics of Patients with End-Stage Kidney Disease in ADPKD
Shukoor, S., Vaughan, L. E., Edwards, M. E., Lavu, S., Kline, T. L., Senum, S. R., Mkhaimer, Y. G., Zaatari, G., Irazabal, M. V., Neal, R. M., et al. (2020) · Kidney International Reports · doi:10.1016/j.ekir.2020.12.016 · Cited by 32
Beyond Macromolecules: Extracellular Vesicles as Regulators of Inflammatory Diseases
Das, K., Paul, S., Mukherjee, T., Ghosh, A., Sharma, A., Shankar, P., Gupta, S. K., Keshava, S., & Parashar, D. (2023) · Cells · doi:10.3390/cells12151963 · Cited by 32
Siddiqui, K., Joy, S. S., George, T. P., Mujammami, M. H., & Alfadda, A. A. (2020) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s282166 · Cited by 29
Tagaya, M., Kume, S., Yasuda‒Yamahara, M., Kuwagata, S., Yamahara, K., Takeda, N., Tanaka, Y., Chin‒Kanasaki, M., Nakae, Y., Yokoi, H., et al. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2022.166368 · Cited by 29
Wen, Y., Thiessen‐Philbrook, H., Moledina, D. G., Kaufman, J. S., Reeves, W. B., Ghahramani, N., Ikizler, T. A., Go, A. S., Liu, K. D., Siew, E. D., et al. (2022) · Kidney International Reports · doi:10.1016/j.ekir.2022.03.026 · Cited by 28
Lan, L., Han, F., Lang, X., & Chen, J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0159964 · Cited by 26
Exploring urinary biomarkers in autosomal dominant polycystic kidney disease
Kawano, H., Muto, S., Ohmoto, Y., Iwata, F., Fujiki, H., Mori, T., Lü, Y., & Horie, S. (2014) · Clinical and Experimental Nephrology · doi:10.1007/s10157-014-1078-7 · Cited by 24
Salah, S. M., Meisenheimer, J. D., Rao, R., Peda, J. D., Wallace, D. P., Foster, D., Li, X., Li, X., Zhou, X., Vallejo, J. A., et al. (2019) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00240.2018 · Cited by 24
dos Santos, T. E. D. J., Gonçalves, R. P., Barbosa, M. C., da Silva, G. B., & Daher, E. D. F. (2014) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2014.11.019 · Cited by 23
Combined detection of uMCP-1 and uTWEAK for rapid discrimination of severe lupus nephritis
Dong, X., Zheng, Z., Ding, J., Luo, X., Li, Z. Q., Li, Y., Rong, M., Fu, Y., Shi, J. H., Yu, L. C., et al. (2018) · Lupus · doi:10.1177/0961203318758507 · Cited by 23
Self-citationBelisário, A. R., Vieira, É. L. M., de Almeida, J. A., Mendes, F. G., de Miranda, A. S., Rezende, P. V., Viana, M. B., & Silva, A. C. S. E. (2019) · Cytokine · doi:10.1016/j.cyto.2019.154800 · Cited by 23
Stem Cells in Kidney Ischemia: From Inflammation and Fibrosis to Renal Tissue Regeneration
Cianci, R., Simeoni, M., Cianci, E., Marco, O. D., Pisani, A., Ferri, C., & Gigante, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054631 · Cited by 23
Animal Models and Renal Biomarkers of Diabetic Nephropathy
Pérez‐López, L., Boronat, M., Melián, C., Brito‐Casillas, Y., & Wägner, A. M. (2020) · Advances in experimental medicine and biology · doi:10.1007/5584_2020_527 · Cited by 22
Ning, J., Xiang, Z., Xiong, C., Zhou, Q., Wang, X., & Zou, H. (2020) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s250347 · Cited by 22
Kidney tissue elastography and interstitial fibrosis observed in kidney biopsy
Islamoglu, M. S., Gülçiçek, S., & Seyahi, N. (2022) · Renal Failure · doi:10.1080/0886022x.2022.2035763 · Cited by 22
Zhou, H., Mu, L., Yang, Z., & Shi, Y. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1113212 · Cited by 21
Self-citationTofik, R., Ohlsson, S., & Bakoush, O. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087857 · Cited by 20
Kim, K., Trott, J. F., Gao, G., Chapman, A. B., & Weiss, R. H. (2019) · BMC Nephrology · doi:10.1186/s12882-019-1249-6 · Cited by 20
Dissecting the differential structural and dynamics features of CCL2 chemokine orthologs
Joshi, N., Nagar, N., Gulati, K., Gangele, K., Mishra, A., Kumar, D., & Poluri, K. M. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.04.067 · Cited by 20
Urinary Biomarkers of Tubular Health and Risk for Kidney Function Decline or Mortality in Diabetes
Chen, T. K., Coca, S. G., Thiessen‐Philbrook, H., Heerspink, H. J. L., Obeid, W., Ix, J. H., Fried, L. F., Bonventre, J. V., El-Khoury, J. M., Shlipak, M. G., et al. (2022) · American Journal of Nephrology · doi:10.1159/000528918 · Cited by 20
Shu, B., Fang, Y., He, W., Yang, J., & Dai, C. (2018) · Cellular Signalling · doi:10.1016/j.cellsig.2018.02.006 · Cited by 19
Elsaid, D. S., Noor, R. A., Shalaby, K. A., & Haroun, R. A. (2021) · Saudi Journal of Kidney Diseases and Transplantation · doi:10.4103/1319-2442.318522 · Cited by 19
Trimarchi, H. (2021) · Pediatric Nephrology · doi:10.1007/s00467-021-05199-1 · Cited by 19
Segarra-Medrano, A., Martín, M., Agraz, I., Vilaprinyó, M., Chamoun, B., Escalante, E. J., Molina, M., Campàs, L. C., García-Carrasco, A., & Roche, S. (2019) · Clinical Kidney Journal · doi:10.1093/ckj/sfz105 · Cited by 18
Moloi, M. W., Rusch, J. A., Omar, F., Ekrikpo, U. E., Dandara, C., Bello, A. K., Jayne, D. R. W., & Okpechi, I. G. (2021) · International Urology and Nephrology · doi:10.1007/s11255-020-02780-9 · Cited by 18
Jensen, M. B., Viken, I., Høgh, F., & Jacobsen, K. K. (2022) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2022.06.014 · Cited by 17
Dehghanbanadaki, H., Forouzanfar, K., Kakaei, A., Zeidi, S., Salehi, N., Arjmand, B., Razi, F., & Hashemi, E. (2022) · PLoS ONE · doi:10.1371/journal.pone.0265619 · Cited by 15
Chanrat, E., Worawichawong, S., Radinahamed, P., Sathirapongsasuti, N., Nongnuch, A., Assanatham, M., Udomsubpayakul, U., & Kitiyakara, C. (2018) · Cytokine · doi:10.1016/j.cyto.2018.01.015 · Cited by 14
Yamashita, S., Shinozaki, T., Murata, H., Matsuyama, Y., & Babazono, T. (2020) · Diabetic Medicine · doi:10.1111/dme.14280 · Cited by 13
Novel Therapeutics for Management of Lupus Nephritis: What Is Next?
Thakare, S. B., So, P. N., Rodriguez, S., Hassanein, M., Lerma, E. V., & Wiegley, N. (2023) · Kidney Medicine · doi:10.1016/j.xkme.2023.100688 · Cited by 13
Hosseinpour, M., Ardalani, F., Mohseni, M., Beheshtian, M., Arzhangi, S., Ossareh, S., Najmabadi, H., Nobakht, A., Kahrizi, K., & Broumand, B. (2022) · Archives of Iranian Medicine · doi:10.34172/aim.2022.95 · Cited by 12
C5a enhances Vδ1 T cells recruitment via the CCL2-CCR2 axis in IgA nephropathy
Deng, S., Zhou, F., Wang, F., Jiang, Y., Tang, J., Hu, X., Luo, L., Jin, Y., Huang, L., Sun, D., et al. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.111065 · Cited by 12
Urushihara, M., Kondo, S., Kinoshita, Y., Ozaki, N., Jamba, A., Nagai, T., Fujioka, K., Hattori, T., & Kagami, S. (2020) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00250.2020 · Cited by 11
Jang, H. R., Jeon, J., Park, J. H., Lee, J. E., Huh, W., Oh, H. Y., & Kim, Y.-G. (2014) · Translational research · doi:10.1016/j.trsl.2014.05.009 · Cited by 9
Mohammad, L. A., Atef, D. M., & Abul-Saoud, A. M. (2015) · Human Immunology · doi:10.1016/j.humimm.2015.09.027 · Cited by 8
Monocyte chemoattractant protein-1 (MCP-1)-2518 A/G polymorphism and lupus nephritis risk
Sang, G., Meng, C., Hao, Y., & Dai, J. (2017) · Medicine · doi:10.1097/md.0000000000009401 · Cited by 7
Treating crescentic glomerulonephritis by targeting macrophages
Chen, A., Lee, K., & He, C. (2022) · Kidney International · doi:10.1016/j.kint.2022.09.004 · Cited by 7
Hattori, T., Fujioka, K., Nagai, T., Kondo, S., Kagami, S., Hirayama, M., & Urushihara, M. (2023) · Pediatric Nephrology · doi:10.1007/s00467-023-06026-5 · Cited by 7
Bernardino, J. I., Alejos, B., Rodríguez-Centeno, J., Esteban-Cantos, A., Mora-Rojas, B., Montejano, R., Buckley, R. D. M., Montero, M., Ayerdi, O., Hernández-Gutiérrez, C., et al. (2023) · Microorganisms · doi:10.3390/microorganisms11071818 · Cited by 6
Jeon, J., Park, J., Boo, H. J., Yang, K. E., Lee, C., Lee, J. E., Kim, K., Kwon, G. Y., Huh, W., Kim, D. J., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-13261-7 · Cited by 5
Lai, Y., Wang, Y., Fan, X., & Zhao, Y. (2022) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2022.06.051 · Cited by 5
Stability of novel urinary biomarkers used for lupus nephritis
Cody, E. M., Rose, J. E., Huang, B., Qiu, T., Brunner, H. I., & Devarajan, P. (2022) · Frontiers in Pediatrics · doi:10.3389/fped.2022.974049 · Cited by 4
Gniewkiewicz, M. S., Gozdowska, J., Dęborska−Materkowska, D., Czerwińska, K., Perkowska‐Ptasińska, A., Burban, A., Cieślik, A., Kosieradzki, M., & Durlik, M. (2023) · Immunity Inflammation and Disease · doi:10.1002/iid3.901 · Cited by 2
Cited by
Alobaidi, S. A. (2025) · Diagnostics · doi:10.3390/diagnostics15101225 · Cited by 114
Lupus Nephritis from Pathogenesis to New Therapies: An Update
Roveta, A., Parodi, E. L., Brezzi, B., Tunesi, F., Zanetti, V., Merlotti, G., Francese, A., Maconi, A., & Quaglia, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25168981 · Cited by 89
Ren, Y., Chen, Y., Zheng, W., Kong, W., Liao, Y., Zhang, J., Wang, M., & Zeng, T. (2025) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.16366 · Cited by 59
Role of Uremic Toxins in Vascular Inflammation Associated with Chronic Kidney Disease
Chermiti, R., Burtey, S., & Dou, L. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13237149 · Cited by 44
Lin, Q., Song, S., Pei, J., Zhang, L., Chen, X., & Jin, H. (2024) · Food Bioscience · doi:10.1016/j.fbio.2024.104647 · Cited by 22
Metadata
- Authors
- Liu, Y., Xu, K., Xiang, Y., Ma, B., Li, H., Li, Y., Shi, Y., Li, S., & Bai, Y.
- Affiliations
- Health Commission of Heilongjiang Province (CN)
- Heilongjiang University of Chinese Medicine (CN)
- First Affiliated Hospital of Harbin Medical University (CN)
- Corresponding author
- Li, Shuju
- Bai, Yan
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2024-01-04
- Volume
- 14
- Pages
- 1303076-1303076
- ISSN
- 1664-3224 (ISSN-L)
- PMC
- PMC10794684
- OpenAlex
- W4390584046
- Cited by
- 93
- References
- 81
- Citations by year
- 2026: 31 · 2025: 45 · 2024: 17
- FWCI
- 6.12
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Immunology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Nephrology › Renal Diseases and Glomerulopathies
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Oncology › Chemokine receptors and signaling
- Keywords
- MCP-1, chemokines, renal inflammation, kidney disease, inflammatory markers, crescentic glomerulonephritis, chronic glomerulonephritis, diabetic nephropathy, lupus nephritis, polycystic kidney disease, sickle cell nephropathy, acute kidney injury, proteinuria, disease severity
- MeSH terms
- Diabetic Nephropathies, Glomerulonephritis, Humans, Inflammation, Lupus Nephritis, Biomarkers, Chemokine CCL2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
